INSIGHT 2
Showing 1 - 25 of >10,000
Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 2
- Validation of new COMs for FSHD2 patients
-
Nice, Alpes M, France
- +5 more
Oct 6, 2023
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Completed
- Presbyopia
- +2 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +4 more
Oct 18, 2022
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Recruiting
- Presbyopia
- +4 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +3 more
Aug 3, 2022
COVID-19, SARS CoV 2 Infection Trial in Minneapolis (LumiraDX, RightSign, Case Control)
Completed
- COVID-19
- SARS CoV 2 Infection
- LumiraDX
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 18, 2022
Myopia, Hyperopia Trial in Waterloo (Lens A (fanfilcon A), Lens B (lotrafilcon B))
Not yet recruiting
- Myopia
- Hyperopia
- Lens A (fanfilcon A)
- Lens B (lotrafilcon B)
-
Waterloo, Ontario, CanadaInsight Eye Care
Oct 19, 2023
Gaining Insight Into the Complexity of Pain in Haemophilia
Recruiting
- Hemophilia A
- Hemophilia B
- Biopsychological pain assessment
-
Edegem, Antwerp, Belgium
- +1 more
Nov 3, 2022
COVID Vaccine Immunity in Kidney Transplant Recipients
Withdrawn
- End Stage Renal Disease
- Kidney Transplant; Complications
- Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Test
- (no location specified)
Oct 25, 2022
Schizophrenia, Schizoaffective Disorder Trial in Montpellier, Nîmes (Video self-observation, Non Self video observation)
Completed
- Schizophrenia
- Schizoaffective Disorder
- Video self-observation
- Non Self video observation
-
Montpellier, France
- +1 more
Dec 29, 2020
Type 2 Diabetes, Chronic Kidney Diseases Trial in United States (Renal Autologous Cell Therapy (REACT®))
Recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
-
Downey, California
- +23 more
Jan 18, 2023
PTSD Trial in Israel, United States (Behavioral: Psychotherapy, MDMA, Placebo)
Completed
- Posttraumatic Stress Disorder
- Behavioral: Psychotherapy
- +2 more
-
Los Angeles, California
- +12 more
Jan 4, 2023
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
Active, not recruiting
- Influenza
- +2 more
- Influenza
-
Norfolk, VirginiaInsight Therapeutics, LLC
Mar 8, 2021
Type 2 Diabetes Trial in Seoul (Group 1, Group 2)
Completed
- Type 2 Diabetes Mellitus
- Group 1
- Group 2
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 21, 2020
PTSD Trial in Canada, Israel, United States (Therapy, MDMA, Placebo)
Completed
- Posttraumatic Stress Disorder
- Therapy
- +2 more
-
North Hollywood, California
- +14 more
Jun 9, 2022
NSCLC Trial in Worldwide (Tepotinib, Osimertinib)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Yuma, Arizona
- +178 more
Dec 19, 2022
Faster Aspart on Insulin-pump Treated T1DM Patients
Completed
- Type 1 Diabetes
- Insulin Faster Aspart
- Insulin pump
-
Ciudad Real, SpainObispo Rafael Torija, St.
Jan 29, 2021
Breastcancer, Breast Tumor Trial in United States (SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b)
Completed
- Breastcancer
- Breast Neoplasm
- SV-BR-1-GM
- +2 more
-
Santa Rosa, California
- +4 more
Jan 27, 2021
Alzheimer, Memory Complaint, Memory Disorders Trial in Paris (procedure, radiation, biological)
Not yet recruiting
- Alzheimer Disease
- +2 more
- Electroencephalogram (EEG)
- +6 more
-
Paris, Ile De France, FranceHôpital Pitié Salpêtrière
Apr 7, 2023
COVID, SARS-CoV2 Infection, Covid19 Trial in Worldwide (Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo)
Recruiting
- COVID
- +2 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- Placebo
-
Washington, District of Columbia
- +37 more
Mar 25, 2022
Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation
Recruiting
- Alzheimer Disease
- +34 more
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
-
Washington, District of Columbia
- +24 more
Jan 27, 2023
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
Chronic Mental Disorders, Peer Support, Psychosocial Skills Training Trial in Samsun (Peer practitioner training - Peer
Recruiting
- Chronic Mental Disorders
- +5 more
- Peer practitioner training - Peer Education Supported Psychosocial Skills Education
- Peer Education Supported Psychosocial Skills Education
-
Samsun, TurkeySamsun Mental Health and Diseases Hospital - Community Mental He
Jul 31, 2023